Gold Bond Ultimate Psoriasis Relief Cream: Package Insert and Label Information

GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM- salicylic acid lotion
Chattem, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Gold Bond Ultimate
Multi-Symptom Psoriasis Relief Cream

Drug Facts

Active ingredient

Salicylic acid 3%

Purposes

Psoriasis, Seborrheic Dermatitis

Uses

For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence

Warnings

For external use only

Ask a doctor before use if

  • condition covers a large area of the body

When using this product

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

  • condition worsens or does not improve after regular use of this product as directed

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

Apply to affected areas one to four times daily or as directed by a doctor

Inactive ingredients

water, hydroxyethyl urea, petrolatum, aminomethyl propanol, glycerin, dimethicone, gluconolactone, steareth-21, jojoba esters, glyceryl stearate, stearyl alcohol, aloe barbadensis leaf juice, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butyrospermum parkii (shea) butter extract, methyl gluceth-20, 7-dehydrocholesterol, bisabolol, ceteareth-25, zea mays (corn) oil, zingiber officinale (ginger) root extract, ceramide NP, hydrolyzed jojoba esters, cetearyl alcohol, stearamidopropyl PG-dimonium chloride phosphate, magnesium ascorbyl phosphate, panthenol, tocopheryl acetate, ceramide EOP, pentylene glycol, ceramide EOS, bis-lauryl cocaminopropylamine/HDI/PEG-100 copolymer, cholesterol, propylene glycol, caprooyl phytosphingosine, polysorbate 60, ceramide NS, cetyl alcohol, isohexadecane, ethylhexylglycerin, 4-t-butylcyclohexanol, ceramide AP, EDTA, behenic acid, butylene glycol, caprooyl sphingosine, methylparaben, tocopherol

PRINCIPAL DISPLAY PANEL

GOLD BOND
ULTIMATE
Multi-Symptom
Psoriasis
Relief Cream
Net wT 4 oz (113 g)

PRINCIPAL DISPLAY PANEL
GOLD BOND
ULTIMATE
Multi-Symptom 
Psoriasis 
Relief Cream
Net wT 4 oz (113 g)
(click image for full-size original)
GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM
salicylic acid lotion
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:41167-0412
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID 3 g in 100 g
Inactive Ingredients
Ingredient Name Strength
WATER
HYDROXYETHYL UREA
PETROLATUM
AMINOMETHYLPROPANOL
GLYCERIN
DIMETHICONE
GLUCONOLACTONE
STEARETH-21
HYDROGENATED JOJOBA OIL, RANDOMIZED
GLYCERYL MONOSTEARATE
STEARYL ALCOHOL
ALOE VERA LEAF
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)
SHEA BUTTER
METHYL GLUCETH-20
7-DEHYDROCHOLESTEROL
LEVOMENOL
CETEARETH-25
CORN OIL
GINGER
CERAMIDE 3
HYDROLYZED JOJOBA ESTERS (ACID FORM)
CETOSTEARYL ALCOHOL
STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE
MAGNESIUM ASCORBYL PHOSPHATE
PANTHENOL
ALPHA-TOCOPHEROL ACETATE
CERAMIDE 1
PENTYLENE GLYCOL
CERAMIDE EOS
CHOLESTEROL
PROPYLENE GLYCOL
POLYSORBATE 60
CERAMIDE 2
CETYL ALCOHOL
ISOHEXADECANE
ETHYLHEXYLGLYCERIN
4-TERT-BUTYLCYCLOHEXANOL
CERAMIDE 6 II
EDETIC ACID
BEHENIC ACID
BUTYLENE GLYCOL
N-HEXANOYLSPHINGOSINE
METHYLPARABEN
TOCOPHEROL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:41167-0412-2 21 g in 1 TUBE None
2 NDC:41167-0412-5 113 g in 1 TUBE None
3 NDC:41167-0412-6 99 g in 1 TUBE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part358H 08/01/2016
Labeler — Chattem, Inc. (003336013)

Revised: 08/2022 Chattem, Inc.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2022. All Rights Reserved.